Showing results (1-10 of 23) with videos related to
Sort By:
Pageof 3
Canadian Critical Care Nursing Journal|March 1, 1991
SvO2 monitoring: limitations and considerationsK L MolnarCanadian Critical Care Nursing Journal|September 1, 1991
New perspectives in shock: expanding our horizonsK L MolnarTransplantation|May 1, 1981
Evidence that strong Mls determinants are nonpolymorphicK L Molnar-Kimber, J SprentJournal of Virology|July 1, 1984
Mapping of the cohesive overlap of duck hepatitis B virus DNA and of the site of initiation of reverse transcriptionK L Molnar-Kimber, J W Summers, W S MasonJournal of Virology|January 1, 1983
Protein covalently bound to minus-strand DNA intermediates of duck hepatitis B virusK L Molnar-Kimber, J Summers, J M Taylor, et al.Journal of Immunology (Baltimore, Md. : 1950)|December 1, 1980
T cell lines with dual specificity for strong Mls and H-2 determinantsK L Molnar-Kimber, S R Webb, J Sprent, et al.Mediators of Inflammation|January 1, 1992
Differential regulation of TNF-alpha and IL-1beta production from endotoxin stimulated human monocytes by phosphodiesterase inhibitorsK L Molnar-Kimber, L Yonno, R J Heaslip, et al.International Journal of Immunopharmacology|April 1, 1992
Strategies for the development of new antiarthritic agentsA J Lewis, K B Glaser, R J Sturm, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 24, 2000
Oncolytic herpes simplex virus-1 lacking ICP34.5 induces p53-independent death and is efficacious against chemotherapy-resistant ovarian cancerG Coukos, A Makrigiannakis, E H Kang, et al.Human Gene Therapy|December 28, 1999
Combined therapy with chemotherapeutic agents and herpes simplex virus type 1 ICP34.5 mutant (HSV-1716) in human non-small cell lung cancerT Toyoizumi, R Mick, A E Abbas, et al.Pageof 3